Literature DB >> 25336367

Optimal pacing for right ventricular and biventricular devices: minimizing, maximizing, and right ventricular/left ventricular site considerations.

Anne M Gillis1.   

Abstract

The results from numerous clinical studies provide guidance for optimizing outcomes related to RV or biventricular pacing in the pacemaker and ICD populations. (1) Programming algorithms to minimize RV pacing is imperative in patients with dual-chamber pacemakers who have intrinsic AV conduction or intermittent AV conduction block. (2) Dual-chamber ICDs should be avoided in candidates without an indication for bradycardia pacing. (3) Alternate RV septal pacing sites may be considered at the time of pacemaker implantation. (4) Biventricular pacing may be beneficial in some patients with mild LV dysfunction. (5) LV lead placement at the site of latest LV activation is desirable. (6) Programming CRT systems to achieve biventricular/LV pacing >98.5% is important. (7) Protocols for AV and VV optimization in patients with CRT are not recommended after device implantation but may be considered for CRT nonresponders. (8) Novel algorithms to maximize the benefit of CRT are in evolution further.

Entities:  

Keywords:  cardiac; cardiac pacemaker, artificial; resynchronization therapy

Mesh:

Year:  2014        PMID: 25336367     DOI: 10.1161/CIRCEP.114.001360

Source DB:  PubMed          Journal:  Circ Arrhythm Electrophysiol        ISSN: 1941-3084


  3 in total

1.  It is time to look at heart failure with preserved ejection fraction from the right side.

Authors:  Neal A Chatterjee; Johannes Steiner; Gregory D Lewis
Journal:  Circulation       Date:  2014-11-12       Impact factor: 29.690

2.  Developments in Cardiac Resynchronisation Therapy.

Authors:  Geoffrey F Lewis; Michael R Gold
Journal:  Arrhythm Electrophysiol Rev       Date:  2015-08

3.  Predictors of pacemaker dependency in patients implanted with a pacemaker after Transaortic valve replacement.

Authors:  Pablo M Ruiz-Hernandez; Esteban Gonzalez-Torrecilla; Enrique Gutierrez-Ibañez; Hugo Gonzalez-Saldivar; Vanesa Bruña; Gerard Loughlin; Evaristo Castellanos; Pablo Avila; Felipe Atienza; Tomas Datino; Jaime Elizaga; Angel Arenal; Francisco Fernández-Aviles
Journal:  Int J Cardiol Heart Vasc       Date:  2020-11-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.